A medication used to treat pulmonary disease is being explored as a possible cure for lung infections caused by COVID-19.<br />Clinical trials of the drug Interferon beta are underway at 10 hospitals, with approximately 75 patients enrolled.<br />According to UPI, researchers expect results to be available by the end of next month.<br />Interferon beta is a naturally occurring protein that's involved in the human body's immune response.<br />Research suggests interferon beta deficiency could be why doctors are seeing more severe lung disease in some patients.<br />The drug, called SNG001, is delivered directly to the lungs with a nebulizer.
